Cargando…

Structural and myocardial dysfunction in heart failure beyond ejection fraction

Heart failure is a multifaceted syndrome addressing for a high rate of death among the general population. The common approach to this disease has been always based on the evaluation of the left ventricular ejection fraction by two-dimensional echocardiography with Simpson’s method. Mounting evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Severino, Paolo, Maestrini, Viviana, Mariani, Marco Valerio, Birtolo, Lucia Ilaria, Scarpati, Rossana, Mancone, Massimo, Fedele, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985184/ https://www.ncbi.nlm.nih.gov/pubmed/31317296 http://dx.doi.org/10.1007/s10741-019-09828-8

Ejemplares similares

Correction to: Structural and myocardial dysfunction in heart failure beyond ejection fraction
por: Severino, Paolo, et al.
Publicado: (2019)

Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets
por: Severino, Paolo, et al.
Publicado: (2021)

Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist
por: Severino, Paolo, et al.
Publicado: (2019)

Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels
por: Severino, Paolo, et al.
Publicado: (2020)

Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction: The Misleading Definition of the New Guidelines
por: Fedele, Francesco, et al.
Publicado: (2017)

Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
por: Severino, Paolo, et al.
Publicado: (2021)

Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients
por: Severino, Paolo, et al.
Publicado: (2023)

Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency
por: Severino, Paolo, et al.
Publicado: (2019)

Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility
por: Severino, Paolo, et al.
Publicado: (2023)

T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study
por: Galea, Nicola, et al.
Publicado: (2021)

Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction
por: Severino, Paolo, et al.
Publicado: (2020)

Myocardial contractility recovery following acute pressure unloading after transcatheter aortic valve intervention (TAVI) in patients with severe aortic stenosis and different left ventricular geometry: a multilayer longitudinal strain echocardiographicanalysis
por: Cimino, Sara, et al.
Publicado: (2020)

Potential Role of eNOS Genetic Variants in Ischemic Heart Disease Susceptibility and Clinical Presentation
por: Severino, Paolo, et al.
Publicado: (2021)

Myocardial Ischemia and Diabetes Mellitus: Role of Oxidative Stress in the Connection between Cardiac Metabolism and Coronary Blood Flow
por: Severino, Paolo, et al.
Publicado: (2019)

3D Echo Characterization of Proportionate and Disproportionate Functional Mitral Regurgitation before and after Percutaneous Mitral Valve Repair
por: Cimino, Sara, et al.
Publicado: (2022)

Protection against Ischemic Heart Disease: A Joint Role for eNOS and the K(ATP) Channel
por: Severino, Paolo, et al.
Publicado: (2023)

The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
por: Calcagno, Simone, et al.
Publicado: (2020)

Triggers for Atrial Fibrillation: The Role of Anxiety
por: Severino, Paolo, et al.
Publicado: (2019)

Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction
por: Park, Jin Joo, et al.
Publicado: (2022)

Effects of Ivabradine on Residual Myocardial Ischemia after PCI Evaluated by Stress Echocardiography
por: Calcagno, Simone, et al.
Publicado: (2019)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

The Mutual Relationship among Cardiovascular Diseases and COVID-19: Focus on Micronutrients Imbalance
por: Severino, Paolo, et al.
Publicado: (2022)

New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events
por: Lavalle, Carlo, et al.
Publicado: (2023)

Heart Failure Pharmacological Management: Gaps and Current Perspectives
por: Severino, Paolo, et al.
Publicado: (2023)

Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View
por: Prosperi, Silvia, et al.
Publicado: (2023)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

Myocardial Contraction Fraction is Superior to Ejection Fraction in Predicting Functional Capacity in Patients with Heart Failure with Reduced Ejection Fraction
por: Abdellatif, Yasser A., et al.
Publicado: (2022)

Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Caputo, Annalisa, et al.
Publicado: (2023)

Added value of hemodynamic forces for left ventricle function evaluation
por: Monosilio, Sara, et al.
Publicado: (2022)

Impaired Myocardial Oxygen Availability Contributes to Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: van Empel, Vanessa P. M., et al.
Publicado: (2014)

ECG evaluation in 11 949 Italian teenagers: results of screening in secondary school
por: Mancone, Massimo, et al.
Publicado: (2022)

Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial Dysfunction
por: Bruno, Carmine, et al.
Publicado: (2020)

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
por: McDiarmid, Adam K., et al.
Publicado: (2019)

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Weerts, Jerremy, et al.
Publicado: (2022)

Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
por: Wenzel, Jan-Per, et al.
Publicado: (2021)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
por: Teuber, James P., et al.
Publicado: (2022)

Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
por: D'Assante, Roberta, et al.
Publicado: (2021)

Vascular Dysfunction Predicts Future Deterioration of Left Ventricular Ejection Fraction in Patients with Heart Failure with Mildly Reduced Ejection Fraction
por: Kishimoto, Shinji, et al.
Publicado: (2021)

Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up
por: Maestrini, Viviana, et al.
Publicado: (2021)

Pharmacological Targets in Chronic Heart Failure with Reduced Ejection Fraction
por: Moloce, Maria-Angela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_455pmgbaukvmkqvvovnkujbhug